Despite a decline in all three U.S. benchmarks over the previous session due to worries about President Donald Trumps tariff plans, Asia-Pacific markets saw a majority of Fridays gains. As of 2:51 PM Singapore time, Hong Kongs Hang Seng Index was up 2.37%, leading the Asian market in gains. WuXi Biologics, a pharmaceutical company, was the indexs top mover, rising 13.95%. Meituan, which jumped 6.32%, Ping An Insurance, which increased 6.23, and BYD, which increased 5.82%, are some other top-performing stocks. The Mainland The healthcare, consumer cyclicals, and non-cyclicals sectors saw stronger movements, which helped Chinas CSI 300 trade 2.26% higher in the last hour. At 7,789.70, Australias S&P/ASX 200 closed the trading day up 0.52%. In Japan, the broader Topix index increased 0.65% to 2,715.85, while the benchmark Nikkei 225 finished the day 0.72% higher at 37,053.10. The small-cap Kosdaq rose 1.59% to 734.26, while the South Korean Kospi index fell 0.28% to close at 2,566.36. These actions follow yet another intensification of the ongoing trade war, in which Trump threatened to impose 200% tariffs on all alcoholic beverages originating from the EU in response to the blocs 50% whiskey tariff. Regarding tariffs, Trump declared on Thursday that "Im not going to bend at all." Uncertainties surrounding Trumps policies "means market risk," according to Michael Strobaek, global chief investment officer at private bank Lombard Odier. “There will be so much for markets to digest, and navigate so many ‘unknown unknowns’,” he wrote in a Friday note. He suggested that investors play the market by “filtering out the noise.” “The macroeconomic and market fundamentals remain solid, but there will be a lot of uncertainty ahead. In the face of volatility, a high degree of diversification is the prudent portfolio response,” Strobaek added.